REQUEST A DEMO
Total
USD $0.00
Search more companies

Inversiones Farmaceuticas La Sante Colombia S A S (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Inversiones Farmaceuticas La Sante Colombia S A S Profile Updated: May 17, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Inversiones Farmaceuticas La Sante Colombia S A S is based in Colombia. The head office is in Bogota D.C.. The company operates in the Pharmaceutical Preparation Manufacturing industry. It was incorporated on June 29, 2011. 1 (2023) employees currently work for Inversiones Farmaceuticas La Sante Colombia S A S. Its total assets decreased by 44.65% over the same period.

Headquarters
Cl 17 A # 32 34
Bogota D.C.; Bogota D.C; Postal Code: 0603

Contact Details: Purchase the Inversiones Farmaceuticas La Sante Colombia S A S report to view the information.

Basic Information
Total Employees:
Purchase the Inversiones Farmaceuticas La Sante Colombia S A S report to view the information.
Outstanding Shares:
Purchase the Inversiones Farmaceuticas La Sante Colombia S A S report to view the information.
Incorporation Date:
June 29, 2011
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Company Performance
Financial values in the chart are available after Inversiones Farmaceuticas La Sante Colombia S A S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
-92.48%
Net Profit (Loss) for the Period
-59.64%
Total assets
-44.65%
Total equity
2.1%
Return on Equity (ROE)
-3.15%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?